Article Text

PDF
Animal models
C05 A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease
  1. L Yu1,
  2. EP Parwez2,
  3. AP Osmand3,
  4. A Redensek1,
  5. S Metzger1,
  6. LE Clemens1,
  7. L Park4,
  8. D Howland5,
  9. C Calaminus6,
  10. X Gu7,
  11. B Pichlern6,
  12. XW Yang7,
  13. O Riess1,
  14. HP Nguyen1
  1. 1Department of Medical Genetics, University of Tuebingen, Tuebingen, Germany
  2. 2Department of Neuroanatomy and Molecular Brain Research, Ruhr-University Bochum, Bochum, Germany
  3. 3Department of Medicine, Graduate School of Medicine, University of Tennessee, Knoxville, Tennessee, USA
  4. 4CHDI Management, CHDI Foundation, Los Angeles, California, USA
  5. 5CHDI Management, CHDI Foundation, Princeton, New Jersey, USA
  6. 6Laboratory for Preclinical Imaging and Imaging Technology, Werner Siemens-Foundation, University of Tuebingen, Tuebingen, Germany
  7. 7Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA

Abstract

Background Huntington disease (HD) is an inherited progressive neurodegenerative disorder, characterised by motor, cognitive and psychiatric deficits as well as neurodegeneration and brain atrophy beginning in the striatum and the cortex and extending to other subcortical brain regions. The genetic cause is an expansion of the CAG repeat stretch in the HTT gene encoding huntingtin protein (htt).

Methods Here, we generated and characterised a HD transgenic rat model using a human bacterial artificial chromosome (BAC) which contains the full-length HTT genomic sequence with 97 CAG/CAA repeats and all regulatory elements.

Results BACHD transgenic rats display a robust, early-onset and progressive HD-like phenotype including motor deficits and anxiety-related symptoms. The phenotype is characterised by striatal dysfunction associated with an imbalance in the striosome and matrix compartments in early stages of the disease. This was, in addition to reduced dopamine receptor binding, readily detectable by in vivo imaging. Neuropathologically, the distribution of neuropil aggregates and nuclear accumulations of N-terminal mutant huntingtin in BACHD rats is similar to that seen in HD patients. Neuropil aggregates in the sensorimotor circuit may be associated with motor dysfunction and aggregates in the limbic-based circuits could be related to anxiety changes and thus render this model suitable for the ongoing research in how these circuits are affected in HD.

Conclusion Taken together, our data demonstrate that this transgenic BACHD rat line may be a valuable model for further understanding the disease mechanisms and for preclinical pharmacological studies.

  • Transgenic rat model
  • BAC
  • striosome
  • full-length mutant huntingtin
  • neurodegeneration
  • animal model

Statistics from Altmetric.com

Footnotes

  • OR and HPN are equal last authors.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.